ADGM
Adagio Medical Holdings, Inc Common Stock
NASDAQ: ADGM · HEALTHCARE · MEDICAL DEVICES
$1.05
-3.67% today
Updated 2026-04-29
Market cap
$23.32M
P/E ratio
—
P/S ratio
205.85x
EPS (TTM)
$-1.51
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
Adagio Medical Holdings, Inc Common Stock (ADGM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $270000.00 | $189000.00 | $300000.00 | $269000.00 | $0.00 |
| Revenue growth (YoY) | — | — | -30.0% | +58.7% | -10.3% | -100.0% |
| Cost of revenue | — | $1.16M | $875000.00 | $1.31M | $1.94M | $684000.00 |
| Gross profit | — | $-888000.00 | $-686000.00 | $-1.01M | $-1.67M | $-684000.00 |
| Gross margin | — | -328.9% | -363.0% | -335.3% | -620.1% | — |
| R&D | — | $15.36M | $17.86M | $15.40M | $4.63M | $10.64M |
| SG&A | — | $6.61M | $1.01M | $4.75M | — | $10.57M |
| Operating income | $-13539.00 | $-20.64M | $-23.91M | $-27.94M | $-62.48M | $-21.89M |
| Operating margin | — | -7646.3% | -12652.4% | -9314.0% | -23226.8% | — |
| EBITDA | $-13539.00 | $-19.60M | $-23.04M | $-27.41M | $-62.48M | $-21.89M |
| EBITDA margin | — | -7260.0% | -12191.0% | -9136.7% | -23226.8% | — |
| EBIT | $-13539.00 | $-19.94M | $-23.54M | $-27.94M | $-54.87M | — |
| Interest expense | — | $0.00 | $137000.00 | $1.66M | $1.10M | $2.91M |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-13539.00 | $-19.94M | $-23.67M | $-38.15M | $-53.76M | $-25.08M |
| Net income growth (YoY) | — | -147163.5% | -18.7% | -61.1% | -40.9% | +53.3% |
| Profit margin | — | -7384.4% | -12525.4% | -12715.3% | -19986.2% | — |